Keywords: altana, eps, rises, first, half, german, drugmaker
Altana's EPS rises 11% in the first half of 2006
Article | 07 August 2006
German drugmaker Altana AG's net income for second-quarter 2006 reached 126.0 million euros ($160.7 million), beating analysts' consensus forecasts of 118.0 million euros. Viewing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
